NIBRT collaborates with Valitacell
Valitacell is partnering with the National Institute of Bioprocessing Research and training (NIBRT) to validate Valitacell’s novel analytical technology known as ChemStress™ which can accelerate the development and manufacture of live-saving biopharmaceutical drugs. The collaboration, which also involves a number of large global biopharmaceutical companies, will demonstrate how Valitacell’s novel analytical platform – ChemStress™can be used as a quality control in cell culture media analysis. NIBRT’s Prof. Johnathan Bones will lead the project, along with Valitacell’s product manager Dr. Karen Coss.
The project is an Innovation Partnership co-funded by Enterprise Ireland, the European Regional Development Fund (ERDF) and the EU. The €206,283 award will run over 18 months and the project will begin in November 2018.
Read the full press release here.